H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 and issues pertaining to pedigree; issues pertaining to drug safety.
Issues concerning new technology IOL payments.
Duration: August 1, 2005
to
December 31, 2011
General Issues: Health Issues , Medicare/Medicaid , Taxation/Internal Revenue Code , Budget/Appropriations , Environmental/Superfund
Spending: about $960,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2005: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), U.S. Senate,, Centers For Medicare and Medicaid Services (CMS),, Executive Office of the President (EOP), Y
Y, Y
Y
U.S. Centers for Medicare and Medicaid Services, Y
Y
Executive Office of The President
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2011
THE NICKLES GROUP, LLC terminated an engagement in which they represented ALCON LABORATORIES, INC. on Jan. 19, 2012.
Original Filing: 300444508.xml
Lobbying Issues
H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 and issues pertaining to pedigree; issues pertaining to drug safety.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues concerning new technology IOL payments.
3rd Quarter, 2011
In Q3, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on Oct. 19, 2011.
Original Filing: 300421650.xml
Lobbying Issues
H.R. 3026, Safeguarding America's Pharmaceuticals Act of 2011 and issues pertaining to pedigree; issues pertaining to drug safety.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 365, the Budget Control Act, issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
S. 365, the Budget Control Act and issues pertaining to Medicare reimbursement.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues concerning new technology IOL payments.
2nd Quarter, 2011
In Q2, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on July 20, 2011.
Original Filing: 300402415.xml
Lobbying Issues
Issues regarding drug safety, track & trace & pedigree.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 17/H.R. 436, Medical Device Access and Innovation Protection Act. Issues related to the taxation of medical devices and pharmaceuticals. Issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H. Con Res 34, fiscal year 2012 budget resolution, issues pertaining to health reform & Medicare reimbursement.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on April 18, 2011.
Original Filing: 300367426.xml
Lobbying Issues
Issues regarding drug safety, track & trace & pedigree.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 17/H.R. 436, Medical Device Access and Innovation Protection Act. HR 2/S. 192, Repealing the Job-Killing Health Care Law Act. Issues related to the taxation of medical devices and pharmaceuticals. Issues related to the taxation of foreign-based multinational corporations, corporate tax reform, and the R&D tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues concerning the NTIOL program.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on Jan. 20, 2011.
Original Filing: 300354162.xml
Lobbying Issues
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act and H.R. 6543, The Drug Safety Enhancement Act as they relate to drug safety and pedigree issues.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4213, The Tax Extenders Act, H.R. 5297, the Small Business Jobs & Credit Act, and H.R. 4853, Tax Relief Unemployment Insurance Reauthorization and Job Creation Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 5712, The Physician Payment & Therapy Relief Act & H.R. 4994, The Medicare & Medicaid Extenders Act of 2010 as they relate to Medicare physician payments.
3rd Quarter, 2010
In Q3, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on Oct. 20, 2010.
Original Filing: 300323439.xml
Lobbying Issues
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree and drug safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4213, The Tax Extenders Act and H.R. 5297, the Small Business Jobs & Credit Act, as they relate to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Issues concerning Medicare reimbursement for ambulatory surgical center and hospital outpatient prospective payment systems.
2nd Quarter, 2010
In Q2, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on July 20, 2010.
Original Filing: 300297688.xml
Lobbying Issues
S. 525, S. 1232 / H.R. 1298, The Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4213, The Tax Extenders Act, as it relates to the research and development tax credit. H.R. 5328, the International Tax Competitiveness Act, as it relates to the taxation of foreign-based multinational corporations.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on April 16, 2010.
Original Filing: 300260043.xml
Lobbying Issues
H.R. 3200, America's Affordable Health Choices Act, H.R. 3590, The Patient Protection & Affordable Health Care Act, H.R. 3962, Affordable Health Care For America Act and H.R. 4872, the Reconciliation Act of 2010, as they relate to drug importation, drug pricing, Sunshine Act and authorized generics.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3200, America's Affordable Health Choices Act, H.R. 3590, The Patient Protection & Affordable Health Care Act, H.R. 3962, Affordable Health Care for America Act, H.R. 4872, the Reconciliation Act of 2010, and issues related to the taxation of medical devices. H.R. 4213, the Tax Extenders Act, as it relates to the research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 3962, Affordable Health Care for America Act and H.R. 3590, The Patient Protection and Affordable Health Care Act, and H.R. 4872, the Reconciliation Act of 2010, as they relate to Medicare reimbursement including policies concerning ASC reimbursement & outpatient hospital issues, Part D reimbursement, and Medicaid Rebates.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on Jan. 20, 2010.
Original Filing: 300243879.xml
Lobbying Issues
H.R. 3200, America's Affordable Health Choices Act, H.R. 3590, The Patient Protection & Affordable Health Care Act, H.R. 3962, Affordable Health Care For America Act, as it relates to drug importation, drug pricing, Sunshine Act and authorized generics.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.506 and H.R.1265, the Stop Tax Haven Abuse Act of 2009, as it relates to the taxation of foreign earnings of multinational corporations. H.R. 3200, America's Affordable Health Choices Act, H.R. 3590, The Patient Protection & Affordable Health Care Act, H.R. 3962, Affordable Health Care for America Act and issues related to the taxation of medical devices. H.R. 4213, the Tax Extenders Act, as it relates to the research and development tax credit.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 3962, Affordable Health Care for America Act and H.R. 3590, The Patient Protection and Affordable Health Care Act, as it relates to Medicare reimbursement including policies concerning ASC reimbursement & outpatient hospital issues; and Part D reimbursement.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on Oct. 20, 2009.
Original Filing: 300220342.xml
Lobbying Issues
H.R. 759, The FDA Globalization Act as it relates to drug safety and pedigree. S. 525 / S. 1232 / H.R. 1298, The Pharmaceutical/Market Access and Drug Safety Act of 2009, as it relates to the importation of prescription drugs and pedigree and drug importation generally. H.R. 3200, America's Affordable Health Choices Act / "America's Healthy Future Act" (unnumbered Senate bill), as it relates to device registry; employer impact; & Sunshine Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.506 and H.R.1265, the Stop Tax Haven Abuse Act of 2009, as it relates to the taxation of foreign earnings of multinational corporations. H.R. 3200, America's Affordable Health Choices Act / "America's Healthy Future Act" (unnumbered Senate bill), and issues related to the taxation of medical devices.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H.R. 3200, America's Affordable Health Choices Act / "America's Healthy Future Act" (unnumbered Senate bill), as it relates to Medicare reimbursement including policies concerning ASC reimbursement & outpatient hospital issues.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on July 20, 2009.
Original Filing: 300187834.xml
Lobbying Issues
H.R. 759, The FDA Globalization Act as it relates to drug safety and pedigree. S. 525 / S. 1232 / H.R. 1298, The Pharmaceutical/Market Access and Drug Safety Act of 2009, as it relates to the importation of prescription drugs and pedigree and drug importation generally. Health care reform as it relates to Medicare and comparative effectiveness.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.506 and H.R.1265, the Stop Tax Haven Abuse Act of 2009, as it relates to the taxation of foreign earnings of multinational corporations. H Con Res 85 and S Con Res 13, FY 2010 budget resolution, as it relates to the taxation of multinational corporations.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H Con Res 85 and S Con Res 13, FY 2010 budget resolution, as it relates to the taxation of multinational corporations and to Medicare reimbursement and prescription drug pricing.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues concerning implementation of the Montreal protocol.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to Medicare reimbursement.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on April 20, 2009.
Original Filing: 300160168.xml
Lobbying Issues
H.R. 759, The FDA Globalization Act as it relates to drug safety and pedigree. S. 525 / H.R. 1298, The Pharmaceutical/Market Access and Drug Safety Act of 2009, as it relates to the importation of prescription drugs and pedigree.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.506 and H.R.1265, the Stop Tax Haven Abuse Act of 2009, as it relates to the taxation of foreign earnings of multinational corporations. H Con Res 85 and S Con Res 13, FY 2010 budget resolution, as it relates to the taxation of multinational corporations. H.R.1, ARRA, as it relates to the taxation of multinational corporations.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
H Con Res 85 and S Con Res 13, FY 2010 budget resolution, as it relates to the taxation of multinational corporations and to Medicare reimbursement and prescription drug pricing. H.R.1, ARRA, as it relates to the taxation of multinational corporations.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Issues concerning implementation of the Montreal protocol.
4th Quarter, 2008
In Q4, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on Jan. 16, 2009.
Original Filing: 300123456.xml
Lobbying Issues
Prescription drug importation and issues concerning anti-counterfeiting and pedigree of prescription drugs, including H.R. 5839, Safeguarding America's Pharmaceutical Act.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on Oct. 17, 2008.
Original Filing: 300099315.xml
Lobbying Issues
Prescription drug importation and issues concerning anti-counterfeiting and pedigree of prescription drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 6331/ S. 3101, The Medicare Improvements for Patients & Providers Act; S. 3118, Preserving Access to Medicare Act of 2008, pay for performance issues.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Prescription drug importation.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on July 21, 2008.
Original Filing: 300080090.xml
Lobbying Issues
Prescription drug importation and issues concerning anti-counterfeiting and pedigree of prescription drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 6331/ S. 3101, The Medicare Improvements for Patients & Providers Act; S. 3118, Preserving Access to Medicare Act of 2008, pay for performance issues.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Prescription drug importation.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, The Nickles Group lobbied for ALCON LABORATORIES, INC. , earning $60,000. The report was filed on April 18, 2008.
Original Filing: 300042609.xml
Lobbying Issues
Prescription drug importation.
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS),
Lobbying Issues
S. Con Res. 70, Budget Resolution; Issues related to Medicare and health care assumptions in Function 570 and 550.
Agencies Lobbied
U.S. House of Representatives
0th Quarter, 2007
In MM, THE NICKLES GROUP, LLC lobbied for ALCON LABORATORIES, INC. , earning $120,000. The report was filed on Aug. 7, 2007.
Original Filing: 200047249.xml
Lobbying Issues
Prescription drug importation.
Lobbying Issues
Medicare reimbursement issues; Ambulatory Surgical Centers; Pay for Performance.
Agencies Lobbied
Y
Y
U.S. Centers for Medicare and Medicaid Services
Lobbying Issues
S. Con Res. 21, Budget Resolution; Issues related to Medicare and Health care assumptions in Function 570 and 550.
Agencies Lobbied
Y
Y
Executive Office of The President
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...